gennarodraisci, Author at European Medical Journal - Page 4 of 8

Current Guidelines on Type 2 Diabetes Management 

Diabetes is predicted to affect 5.5 million individuals by 2030 in the UK alone. There is no known cure for this increasingly common condition and current treatment includes medication, weight loss surgery, and lifestyle changes.

Continuous Glucose Monitoring with Multiple Daily Insulin Injections Improves Perinatal Outcomes in Females with Type 1 Diabetes Mellitus

Females with Type 1 diabetes mellitus (T1DM) are at increased risk of adverse pregnancy outcomes.1 Compared to the general population, there is a higher prevalence of congenital malformations, caesarean delivery, fetal macrosomia, large for gestational age (LGA) infants, pre-eclampsia, preterm delivery, and neonatal mortality.2-4

Screening for Heart Failure in Diabetes: A Way to Reduce Its Prevalence? A Proof of Concept of a Risk Assessment Tool

Patients with diabetes have a two-fold increase in the risk of heart failure (HF).

Socio-demographic Determinants of Attendance in Diabetes Education Centres: A Survey of Patients’ Views

People with long-term conditions such as diabetes are at greater risk of comorbidity, and anecdotal evidence suggests that it can increase the burden of ongoing COVID-19 pandemic infection.1-3

Interview: Neel Basudev

To be honest, my initial foray into the field of diabetes was by chance, as I took on the management of diabetes at the practice when I joined as a salaried general practitioner.

A Phase II Prospective Trial of Frontline Cabozantinib in Metastatic Collecting Ducts Renal Cell Carcinoma: the BONSAI Trial (Meeturo 2)

Metastatic collecting ducts carcinoma is biologically poorly characterised and under-represented in prospective randomised trials.

Colorectal Cancer Screening and Diagnosis During the COVID-19 Pandemic in Québec, Canada

Colorectal cancer (CRC) is the third most common cancer in Québec, Canada…

Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer

In this study, the serologic status and safety of the SARS-CoV-2 BNT162b2 vaccine in a cohort of patients with solid tumors is evaluated

Interview: Sarah Walmsley

As a medical student in Edinburgh, I was inspired by the opportunities in Edinburgh to combine clinical and basic science research in respiratory medicine.

Interview: Andres Floto

I have always been incredibly interested in science and in trying to understand how things work. My first degree was in natural sciences at Cambridge, UK, where I specialised in neurobiology, and this exposed me to the beauty and rigor of basic science.